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Potential Health Problems Related to Formaldehyde 
Among People Living in Mobile Homes or Travel Trailers
In the aftermath of Hurricane Katrina, the Federal Emergency Management Agency (FEMA) 
provided either mobile homes or travel trailers to Gulf Coast victims who had lost their homes in 
the hurricane. Currently, nearly 65,000 households occupy units in Alabama, Louisiana, 
Mississippi, and Texas. Most (97%) of the units are located in Louisiana and Mississippi. 
Concerns have surfaced recently about air quality in the trailers and the occurrence of respiratory 
and other symptoms resulting from exposure to formaldehyde or other respiratory irritants among 
residents of the mobile homes. CDC is working with FEMA to investigate the health concerns of 
those living in the trailers and mobile homes.
Persons who live in mobile homes and travel trailers and are concerned about formaldehyde 
exposure have been directed to seek medical treatment. If these persons present with 
respiratory symptoms, formaldehyde exposure should be considered as a contributing factor.
CDC provides in this document current knowledge about formaldehyde for clinicians that may 
assist them in addressing patients’ symptoms and concerns.
Formaldehyde is a volatile organic compound that is released as a gas from adhesives (urea­
formaldehyde resins) that are used to make products such as particle board, plywood, and 
hardwood paneling. These materials are used extensively in mobile homes and travel trailers, but 
formaldehyde can be found in almost all buildings and homes. Formaldehyde is also released 
from urea-formaldehyde foams in wall insulation. Older homes and mobile homes may contain 
this form of insulation although it is used less frequently today. Formaldehyde is also used in 
fertilizers and some household items such as carpets, permanent-press fabrics, and household 
cleaners.
Patients who have been exposed to formaldehyde may present a variety of symptoms. 
Formaldehyde can irritate the skin, eyes, nose, throat, sinuses, and lungs, resulting in itching, 
watery eyes, and cough. Some people may develop skin rashes. Others may experience difficulty 
in breathing with wheezing and bronchoconstriction. At-risk populations with underlying asthma, 
pulmonary disease, or other comorbidities may be more severely affected. These signs and 
symptoms may also be caused by other air-borne irritants or allergens including mold, tobacco 
smoke, pets, mites, cockroaches, and urban smog. People can smell formaldehyde when it is at 
very low levels, but they can also manifest symptoms even when they cannot smell the chemical.
Diagnosis of formaldehyde reaction is based on clinical grounds including a history of exposure, 
symptoms consistent with formaldehyde, a temporal association of exposure with symptoms, and 
the exclusion of alternative explanations for the symptoms. Some people react to formaldehyde 
at very low levels of exposure. Among sensitive individuals, formaldehyde antibodies (IgG and/or 
IgE) may form, but no antibody test has been validated for routine diagnostic use. Diagnostic 
challenge in an exposure chamber is a theoretical approach to confirming the diagnosis, but is 
not recommended for routine clinical use.
There is no specific antidote or treatment for environmental exposure. Exposure to formaldehyde 
should be treated symptomatically. Asthma associated with formaldehyde exposure should be 
treated with the usual approach to asthma with consideration given to avoiding specific exposures
and allergens and using beta agonist bronchodilators and steroids, depending on the judgment of 
the health care provider and the patient’s comorbidities. Symptoms should lessen if the affected 
individual is removed from the area of exposure. Patients should be encouraged to open windows 
and use fans to bring fresh air indoors as ways to reduce exposure to formaldehyde.
Clinicians can access additional information about indoor air pollution and formaldehyde at 
http://www.epa.gov/iaq/formalde.html.
For emergent information about acute exposures health care providers should contact their local 
poison control center. Call 1-800-222-1222 to locate the nearest poison control center. More 
information about the American Association of Poison Control Centers is available at 
www.aapcc.org.
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